November 7, 2025 ~ Mark Fendrick, Professor in the Division of General Medicine, Department of Internal Medicine and Department of Health Management, and Policy at the University of Michigan, joins Kevin after President Donald Trump announced deals with Eli Lilly and Novo Nordisk to slash the prices of some of their obesity drugs, in an effort to expand access to the costly blockbuster treatments.